Proteome Sciences plc PRM.L Stock
Proteome Sciences plc Price Chart
Proteome Sciences plc PRM.L Financial and Trading Overview
Proteome Sciences plc stock price | 3.25 GBP |
Previous Close | 6.03 GBP |
Open | 6.5 GBP |
Bid | 5.55 GBP x 0 |
Ask | 6.5 GBP x 0 |
Day's Range | 6.5 - 6.5 GBP |
52 Week Range | 3.15 - 7 GBP |
Volume | 769 GBP |
Avg. Volume | 290.69K GBP |
Market Cap | 19.19M GBP |
Beta (5Y Monthly) | -0.059386 |
PE Ratio (TTM) | Infinity |
EPS (TTM) | -0.01 GBP |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6 GBP |
PRM.L Valuation Measures
Enterprise Value | 25.78M GBP |
Trailing P/E | Infinity |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.466174 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 3.314 |
Enterprise Value/EBITDA | 14.056 |
Trading Information
Proteome Sciences plc Stock Price History
Beta (5Y Monthly) | -0.059386 |
52-Week Change | 68.05% |
S&P500 52-Week Change | 20.43% |
52 Week High | 7 GBP |
52 Week Low | 3.15 GBP |
50-Day Moving Average | 4.55 GBP |
200-Day Moving Average | 4.23 GBP |
PRM.L Share Statistics
Avg. Volume (3 month) | 290.69K GBP |
Avg. Daily Volume (10-Days) | 391.41K GBP |
Shares Outstanding | 295.18M |
Float | 117.61M |
Short Ratio | N/A |
% Held by Insiders | 21.48% |
% Held by Institutions | 23.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 17.03% |
Operating Margin (ttm) | 22.21% |
Gross Margin | 61.27% |
EBITDA Margin | 23.57% |
Management Effectiveness
Return on Assets (ttm) | 9.60% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 7.78M GBP |
Revenue Per Share (ttm) | 0.03 GBP |
Quarterly Revenue Growth (yoy) | 43.60% |
Gross Profit (ttm) | N/A |
EBITDA | 1.83M GBP |
Net Income Avi to Common (ttm) | 1.33M GBP |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | 153.90% |
Balance Sheet
Total Cash (mrq) | 3.99M GBP |
Total Cash Per Share (mrq) | 0.01 GBP |
Total Debt (mrq) | 11.92M GBP |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.552 |
Book Value Per Share (mrq) | -0.003 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.14M GBP |
Levered Free Cash Flow (ttm) | 434.38K GBP |
Profile of Proteome Sciences plc
Country | United Kingdom |
State | N/A |
City | Cobham |
Address | Coveham House |
ZIP | KT11 3EP |
Phone | 44 20 7043 2116 |
Website | https://www.proteomics.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
Q&A For Proteome Sciences plc Stock
What is a current PRM.L stock price?
Proteome Sciences plc PRM.L stock price today per share is 3.25 GBP.
How to purchase Proteome Sciences plc stock?
You can buy PRM.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Proteome Sciences plc?
The stock symbol or ticker of Proteome Sciences plc is PRM.L.
Which industry does the Proteome Sciences plc company belong to?
The Proteome Sciences plc industry is Diagnostics & Research.
How many shares does Proteome Sciences plc have in circulation?
The max supply of Proteome Sciences plc shares is 2.95M.
What is Proteome Sciences plc Price to Earnings Ratio (PE Ratio)?
Proteome Sciences plc PE Ratio is now.
What was Proteome Sciences plc earnings per share over the trailing 12 months (TTM)?
Proteome Sciences plc EPS is -0.01 GBP over the trailing 12 months.
Which sector does the Proteome Sciences plc company belong to?
The Proteome Sciences plc sector is Healthcare.
Proteome Sciences plc PRM.L included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
FTSE AIM All-Share Index FTAI | 755.91 GBP 966.76 USD |
-0.38
|
— — | 755.91 GBP 966.76 USD | 763.17 GBP 976.05 USD | — - | — — |
- {{ link.label }} {{link}}